 |
The 130th Annual Meeting of APHA |
|
The 130th Annual Meeting of APHA |
3344.0: Monday, November 11, 2002: 8:30 PM-10:00 PM | |||
Oral | |||
| |||
| Performance measures estimate or monitor the extent to which the actions of a health care practitioner or provider conform to practice guidelines, medical review criteria, or standards of quality. Alcohol and other drug disorders present special challenges in terms of performance measurement, because these illnesses are unique among chronic disorders. In vulnerable individuals, these chemicals can disrupt users' awareness of satiety; result in behavioral dyscontrol, danger and illness; and reinforce patients' tendencies to exacerbate their illnesses. In addition, patient/provider relationships are complicated when addressing substance use disorders. Nonetheless, performance measures are needed to establish clear standards of accountability that, in turn, will lead to efforts to improve the quality of care for people with AOD disorders. The purpose of this session is to present new performance measures for AOD services, and to explore the complex issues involved in developing, calculating, and using performance measures in this area. | |||
| Learning Objectives: See below. | |||
| See individual abstracts for presenting author's disclosure statement and author's information. | |||
| John Bartlett, MD | |||
| Joachim Roski, PhD, MPH | |||
| John Bartlett, MD | |||
| Performance measures for substance abuse: Opportunities and challenges (SESSION ABSTRACT) John Bartlett, MD, Mady Chalk, PhD, Deborah W Garnick, ScD, David Gastfriend, MD, Constance Weisner, DrPH, MSW | |||
| Measuring initiation of treatment following detoxification from alcohol and/ or drugs Mady Chalk, PhD | |||
| Establishing the feasibility of performance measures for alcohol and other drugs Deborah W Garnick, ScD, Margaret T. Lee, PhD, Mady Chalk, PhD, David Gastfriend, MD, Constance M. Horgan, ScD, Frank McCorry, PhD, A.Thomas McLellan, PhD, Elizabeth L. Merrick, PhD, MSW | |||
| Policy implications for measuring performance of alcohol and other drug services in health plans David Gastfriend, MD, Deborah W Garnick, ScD, John Bartlett, MD, Suzanne Gelber, PhD, Mady Chalk, PhD, Constance M. Horgan, ScD, Frank McCorry, PhD, Estee Sharon, PsyD | |||
| Examining the importance of performance measures for substance abuse services for adolescents Constance Weisner, DrPH, MSW, Jennifer Mertens, MA, Stacy Sterling, MPH, MSW, Sujaya Parthasarathy, PhD, Michele Scott | |||
| Discussion | |||
| Organized by: | Alcohol, Tobacco, and Other Drugs | ||
| Endorsed by: | School Health Education and Services | ||
| CE Credits: | CME, Health Education (CHES), Nursing, Pharmacy, Social Work | ||